Deoxysugars as antituberculars and alpha-mannosidase inhibitors.
Journal:
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 6Abstract:
A promising modified sugar molecule was identified which was active against multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, suggesting involvement of a new target. The compound was demonstrated to be bactericidal, inhibited the growth of M. tuberculosis in mice, and targeted alpha-mannosidase as a competitive inhibitor with a Ki value of 353.9 μM.
Courtesy of the U.S. National Library of Medicine